The Opportunity
May 14th, 2025 | New York, USA
EMD Serono, a global leader in reproductive health, and M Ventures, their strategic corporate venture arm, are scouting for new breakthrough innovations to transform patient care.
Shortlisted companies will have exclusive access to pitch their innovations and explore partnership and investment opportunity with the most influential decision-makers.
- Application Deadline: April 17th, 2025
- Shortlist Announced: April 25th, 2025
- E.S.C.A: May 14th, 2025
A Full Day of Exclusive Access
Privately Pitch Your Innovation
Private 30-minute meetings with EMD Serono and M Ventures leadership. Present your innovation, receive direct feedback, and explore partnership opportunities with one of the world's leading reproductive health companies.
Innovation Deep-Dive Discussions
Join an intimate roundtable with EMD Serono executives and M Ventures investors to tackle key challenges in reproductive health. Share insights, shape future collaborations, and position your solution alongside fellow innovators.
VIP Networking
Reception
Cap off a transformative day by building lasting connections over cocktails. Network with EMD Serono decision-makers, M Ventures investors, and fellow founders in an exclusive setting.
Meet the Decision Makers
Sebastian Bohl
VP, Global Head New Businesses Fertility
Merck KGaA, Darmstadt, Germany
Margaux Bruneau de La Salle
Senior Manager, Global Business Development
Merck KGaA, Darmstadt, Germany
Hakan Goker
Managing
Director
M Ventures
Julia Barysheva
Head of Marketing Strategy & Portfolio Planning
EMD Serono
Jan Möller
VP, Head of
Global BD
Merck KGaA, Darmstadt, Germany
Focus Areas
The ESCA project team are particularly interested in innovative solutions addressing:
Infertility
Endometriosis
Polycystic Ovary Syndrome (PCOS)
Ovarian Insufficiency
Telehealth
Patient Journey
